Apricus Biosciences, Inc.
(NASDAQ : APRI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
0.45%177.110.4%$130.27m
PRGOPerrigo Co. Plc
0.05%72.616.8%$98.12m
MNKMallinckrodt Plc
0.03%29.6821.1%$71.62m
JAZZJazz Pharmaceuticals Plc
0.13%161.222.2%$69.92m
ENDPEndo International Plc
0.69%15.968.9%$60.07m
PTLAPortola Pharmaceuticals, Inc.
-0.49%28.267.7%$40.35m
UTHRUnited Therapeutics Corporation
-0.34%125.5114.4%$39.03m
SAGESAGE Therapeutics, Inc.
1.53%147.359.6%$37.38m
CTLTCatalent Inc
0.47%42.772.4%$36.66m
ICPTIntercept Pharmaceuticals, Inc.
0.98%119.9318.7%$31.42m
GWPHGW Pharmaceuticals PLC Sponsored ADR
4.09%146.706.8%$30.46m
ZGNXZogenix, Inc.
0.72%48.8511.9%$30.07m
SUPNSupernus Pharmaceuticals, Inc.
4.35%48.006.2%$28.36m
MDCOMedicines Company
1.52%34.0721.8%$25.39m
ICLRICON Plc
0.96%146.674.2%$24.06m

Company Profile

Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA.